Business Context and Reporting Period
This Form 8-K was filed by China BAK Battery, Inc. on March 14, 2013, reporting an event that occurred on March 8, 2013. The filing addresses a compliance issue with The NASDAQ Stock Market regarding the composition of the Company's board of directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
The material change reported is the resignation of Charlene Spoede Budd as a member of the board of directors and the audit committee. Consequently, the Company no longer complies with Nasdaq Listing Rule 5605, which mandates specific requirements for independent directors and audit committee composition.
Guidance, Outlook, and Risks
- Delisting Risk: The Company received a notification of failure to satisfy a continued listing rule. If compliance is not restored, the Company faces potential delisting.
- Cure Period: Nasdaq has granted a cure period to regain compliance. The deadline is the earlier of the Company's next annual shareholders' meeting or February 27, 2014. If the next annual meeting is held before August 26, 2013, compliance must be evidenced by August 26, 2013.
- Management Action: Management stated the Company is actively seeking a new independent director to fill the vacancies and intends to regain compliance as soon as practicable.
Key Facts for Investor Verification
- Verify the timeline for the appointment of a new independent director to ensure the cure period deadline is met.
- Confirm the date of the next annual shareholders' meeting to determine the exact compliance deadline.
- Monitor subsequent filings for updates on the board composition and any further correspondence from Nasdaq.